
COURSE CREDITS & HOURS
14 AMA PRA Category 1 Credits™14 ANCC Contact Hours
13 Hours of Pharmacology for NPs
COURSE FEES
TARGET AUDIENCE
PROGRAM TOPICS
- Review new classes of medications for diabetes treatment with impact on CV outcomes, review 2017, 2018 CV outcomes data for GLP 1 agonists, SGTI, and summarize other CV data for older diabetes medications.
- Evaluate role of biomarkers such as Apo B and LDL P in cardiovascular risk assessment for primary and secondary prevention as well as management.
- Review impact of biomarkers such as lipoprotein (a), homocystine and inflammation markers on cardiovascular disease treatment.
- Discuss impact of epidemic of obesity and treatment approach to work up and management of patients impacted by obesity and its comorbities.
- New Diabetes Medications that Improve Cardiovascular Outcomes
- Review cardiovascular outcomes data for currently available diabetes medications including review of new classes of agents, GLP-1 agonists, SGT2 inhibitors, QR bromocriptine
- Obesity from the Perspective of a Lipidologist: Root Cause Analysis
- Identify medical factors, medications, insulin resistance as secondary causes of obesity and how to work up, address and treat these conditions
- Discuss how diet, genomics, microbiome and environmental factors influence the treatment of obese patients.
- Lipoprotein (a), Homocysteine, Hypercoagulation and CV risk
- Review lp (a), homocystine, MTHFR as risk factors for cardiovascular disease.
- Discuss how to interpret and treat these biomarkers.
- Heart Disease in Women: Putting Prevention into Practice
- Review cardiometabolic risk in women, use of advanced biomarkers and clinical application.
- Complex lipid management: case study review
- Develop practical approach to using advanced lipid testing as well as treatment approach to reduce residual risks in patients with high risk for events.
- Biomarkers: Role of Apo B, LDL-P vs LDL -C in primary and secondary prevention cardiovascular disease, also inflammation
- Review outcomes data for Apo B LDL P and cost effective approach to treatment using advanced testing.
- Learn concept of discordance of LDL C vs LDL P or ApoB
-
Tools for Pulmonary Evaluation
- Gain understanding of the American Thoracic Society guidelines for pulmonary function testing and
- Analyze date from cardiopulmonary stress testing and apply this data in the evaluation of patients with unexplained dyspnea.
- Review criteria for oxygen qualification. Understand the guideline recommendations for patient evaluation and use of oxygen during air travel.
- COPD: Medical and Non-medial treatments.
- Utilize the most recent GOLD guidelines to direct medical therapy.
- Identify COPD patients that may benefit from surgical and non-surgical lung volume reduction.
- Review the role of NIV in both the acute and stable COPD patient.
- Treatment of Uncontrolled Asthma
- Understand expert consensus recommendations for accessing asthma control.
- Apply these expert consensus recommendations to the management of asthma patients.
- Review data on several recently FDA approved medial treatments for asthma and FDA approved bronchoscopic interventions for asthma treatment .
- Interstitial Lung Disease: IPF and Sarcoid
- Recognize the broad differential diagnosis of diffuse parenchymal lung disease.
- Understand the ATS/ERS diagnostic criteria for IPF.
- Understand the various clinical measures predictive of IPF survival and how they are affected by two recent FDA approved medications.
- Recognize the clinical presentation of pulmonary sarcoid.
- Formulate a treatment plan for pulmonary and cardiac sarcoid.
- Pulmonary Nodule Guidelines and Lung Cancer Screening.
- Describe characteristics of pulmonary nodules that influence clinical suspicion for benign or malignant character.
- Apply recommended guidelines for following sold, ground glass, and part solid pulmonary nodules.
- Understand the key elements of lung cancer screening and identify patients who are candidates for screening.
- Acute Respiratory Distress Syndrome: Clinical update 2019.
- Define ARDS using Belin criteria.
- Apply non-invasive ventilation in the management of ARDS.
- Understand current recommendations for mechanical ventilation in patients with ARDS.
- Apply salvage strategies such as prone positioning, ECMO, paralytics, and vasodilators in refractory ARDS.
- Pulmonary Embolism: Treating patients based on risk stratification: a review of the literature and evidence-based guidelines.
- Understand the risk stratification used for acute PE.
- Apply radiological imaging, laboratory markers in risk stratification of PE
- Understand treatment outcomes of high and intermediate risk patients with PE treated with thrombolysis vs standard anticoagulation.
- Apply current ACCP recommendations for duration of treatment of acute PE.
































